<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8086">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03001674</url>
  </required_header>
  <id_info>
    <org_study_id>IABP_Hemodynamics</org_study_id>
    <nct_id>NCT03001674</nct_id>
  </id_info>
  <brief_title>Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure</brief_title>
  <official_title>Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to develop normative hemodynamic data (means and
      standard deviations) for the intra-aortic balloon pump (IABP) using pressure-volume loop and
      3D-echocardiographic analyses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome measure is the impact of intra-aortic balloon pump activation on left ventricular stroke work.</measure>
    <time_frame>24 hours</time_frame>
    <description>We will be measuring left ventricular stroke work using a conductance catheter before and immediately after activation of an intra-aortic balloon pump (IABP). Left ventricular stroke work is quantified as the product of left ventricular pressure and volume. Conductance catheters are the primary method available for clinical measurement of left ventricular volume and pressure.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>IABP recipient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prospective, single-arm, pilot study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conductance catheterization</intervention_name>
    <description>CD Leycom Conductance Catheter</description>
    <arm_group_label>IABP recipient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or females between 18-75 years of age

          -  NYHA Class III-IV heart failure at the time of MEGA deployment

          -  Stage C-D systolic heart failure

          -  Non-ischemic cardiomyopathy

          -  Preserved right ventricular function defined by 2D-echocardiography

          -  Clinically indicated left and right heart catheterization and MEGA-IABP placement

          -  Clinically indicated MEGA-IABP support for 12 hours minimum

        Exclusion Criteria:

          -  Ischemic cardiomyopathy

          -  Active myocardial ischemia or acute coronary syndrome

          -  Severe peripheral vascular disease

          -  Severe aortic or mitral valve insufficiency

          -  Severe aortic or mitral valve stenosis

          -  Right ventricular failure

          -  Inability to tolerate left and right heart catheterization

          -  Severe hemodynamic instability defined as a systolic BP &lt;80mmHg despite
             vasopressor/inotropic support

          -  Sustained ventricular tachycardia (&gt;10 beats) within 24 hours and/or ventricular
             fibrillation within 24 hours

          -  Pacemaker dependent rhythm

          -  Left ventricular thrombus

          -  Rapid atrial fibrillation (HR&gt;120 bpm)

          -  Unable to provide informed consent

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Navin Kapur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 20, 2016</lastchanged_date>
  <firstreceived_date>March 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
